Dr Jennifer Ligibel discusses findings with ecancer at ASCO 2026 from the phase III BWEL study evaluating a lifestyle-based weight loss intervention in patients with stage II–III breast cancer and overweight or obesity.

The intervention showed that patients significantly improved physical function, physical and mental health, social participation, and fatigue compared with health education alone, with benefits largely maintained over two years.